BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Clofibrate

A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)

299+ PubMed studies analyzed · 15 RCTs · Evidence Score: 45.2

Research Domains

Clofibrate has been studied across 18 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 😴 Sleep, 🫁 Liver & Detox, ⚡ Energy & Fatigue. The primary research focus is 🔥 Metabolic with 41% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Clofibrate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Fenofibrate
12 shared targets
Linezolid
6 shared targets
Prednisone
6 shared targets
Pinacidil
4 shared targets
Tolazamide
6 shared targets
ethopropazine
7 shared targets
Iodine
4 shared targets
Robenidine
5 shared targets
Lactic
4 shared targets
Sulfadoxine
4 shared targets
Loading evidence profile...

This evidence profile for Clofibrate is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.